Prasanna, ThiruWu, FanYip, DesmondRao, Sudha2022-08-101524-9557http://hdl.handle.net/1885/270336T Prasanna is supported by Deep Water Scholarship. D Yip declared no conflicts of interest. S Rao is a Chief Scientific Officer of EpiAxis Therapeutics Pty Ltd. In accordance with NHMRC guidelines and ethical obligations as researchers, S Rao and F Wu report a financial interest in EpiAxis Therapeutics Pty Ltd. S Rao and F Wu also has in place a plan for managing any potential conflicts arising from that involvement.application/pdfen-AU© 2019 Future Medicine Ltdcancer stem cellsepigeneticsimmune checkpointLSD1T cell201910.2217/imt-2019-01402021-08-01